EFFECT OF PERSONALIZED GENOMIC-GUIDED CHEMOTHERAPY REGIMENS ON TREATMENT OUTCOMES IN BRCA-MUTATED BREAST CANCER PATIENTS. Axis Journal of Medical and Biosocial Sciences, [S. l.], v. 2, n. 1, p. 15–26, 2025. Disponível em: https://axisjmbs.com/index.php/home/article/view/12. Acesso em: 2 may. 2026.